"Erlanger’s neurology specialists treat adult and pediatric patients with a variety of neurological disorders ranging from the common to the complex. As a certified academic Neurosciences Center, we provide a comprehensive, multidisciplinary approach to care, giving our patients access to more specialty and subspecialty services than any area health system."

During the past decade, Chattanooga Neurology Associates (Erlanger Hospital) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chattanooga Neurology Associates (Erlanger Hospital)" #1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chattanooga Neurology Associates (Erlanger Hospital)" are "Acute Ischemic Stroke" (1 trials) and "Cerebrovascular Accident" (1 trials). Many other conditions were trialed in "Chattanooga Neurology Associates (Erlanger Hospital)" in a lesser frequency.

Most popular intervention types in "Chattanooga Neurology Associates (Erlanger Hospital)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "YM872 (zonampanel)" (1 trials) and "YM872 (zonampanel), t-PA (alteplase)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chattanooga Neurology Associates (Erlanger Hospital)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Chattanooga Neurology Associates (Erlanger Hospital)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chattanooga Neurology Associates (Erlanger Hospital), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chattanooga Neurology Associates (Erlanger Hospital), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".